1. Home
  2. SBI vs XGN Comparison

SBI vs XGN Comparison

Compare SBI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Intermediate Muni Fund Inc

SBI

Western Asset Intermediate Muni Fund Inc

HOLD

Current Price

$7.82

Market Cap

108.9M

Sector

Finance

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.36

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBI
XGN
Founded
1992
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.9M
110.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SBI
XGN
Price
$7.82
$4.36
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
35.7K
372.0K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
4.52%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.40
$2.59
52 Week High
$8.01
$12.23

Technical Indicators

Market Signals
Indicator
SBI
XGN
Relative Strength Index (RSI) 53.66 52.87
Support Level $7.79 $4.11
Resistance Level $7.90 $4.85
Average True Range (ATR) 0.07 0.38
MACD 0.01 -0.07
Stochastic Oscillator 54.55 38.57

Price Performance

Historical Comparison
SBI
XGN

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: